Novo Nordisk A/S Company Profile (NYSE:NVO)

About Novo Nordisk A/S

Novo Nordisk A/S logoNovo Nordisk A/S is a healthcare company. The Company is engaged in discovery, development, manufacturing and marketing of pharmaceutical products. The Company's business segments include diabetes and obesity care, and biopharmaceuticals. The diabetes and obesity care segment covers insulins, glucagon-like peptide-1 (GLP-1), other protein-related products (such as glucagon, protein-related delivery systems and needles), oral anti-diabetic drugs and obesity. The biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. It offers a range of diabetes product, including new generation insulins and a portfolio of modern insulin. It provides Saxenda, which is a product to treat obesity and is available in Denmark, Italy and Canada. Its other products/compounds include Xultophy, Semaglutide (NN9535), Faster-acting insulin aspart (NN1218), N9-GP (NN7999), N8-GP (NN7088) and NN8640 Once-weekly human growth hormone.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: NVO
  • CUSIP:
Key Metrics:
  • Previous Close: $46.85
  • 50 Day Moving Average: $52.08
  • 200 Day Moving Average: $53.63
  • Trailing P/E Ratio: 21.76
  • Foreward P/E Ratio: 18.74
  • P/E Growth: 1.95
  • Market Cap: $118.83B
  • Outstanding Shares: 2,536,300,000
  • Beta: 0.8
Additional Links:
Companies Related to Novo Nordisk A/S:

Analyst Ratings

Consensus Ratings for Novo Nordisk A/S (NYSE:NVO) (?)
Ratings Breakdown: 2 Hold Ratings, 3 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $56.00 (19.53% upside)

Analysts' Ratings History for Novo Nordisk A/S (NYSE:NVO)
DateFirmActionRatingPrice TargetDetails
8/8/2016Bank of America Corp.DowngradeBuy -> NeutralView Rating Details
8/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
6/28/2016Goldman Sachs Group Inc.DowngradeConviction-Buy -> BuyView Rating Details
1/26/2016Oddo SecuritiesUpgradeNeutral -> BuyView Rating Details
9/21/2015SwedbankUpgradeStrong-BuyView Rating Details
8/28/2015Leerink SwannInitiated CoverageMarket Perform$56.00View Rating Details
8/10/2015Main First Bank AGDowngradeHoldView Rating Details
6/25/2015HSBCInitiated CoverageReduceView Rating Details
6/9/2015Morgan StanleyUpgradeEqual Weight -> OverweightView Rating Details
4/15/2015Societe GeneraleInitiated CoverageSellView Rating Details
3/26/2015Bryan, Garnier & CoDowngradeNeutralView Rating Details
1/29/2015Commerzbank AGDowngradeHoldView Rating Details
11/25/2014BNP ParibasInitiated CoverageNeutralView Rating Details
(Data available from 8/26/2014 forward)


Earnings History for Novo Nordisk A/S (NYSE:NVO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/29/2016Q1$0.53$0.57ViewListenView Earnings Details
10/29/2015Q3$0.47$0.48ViewN/AView Earnings Details
8/6/2015Q215$3.31$3.23$3.98 billion$27.06 billionViewN/AView Earnings Details
4/30/2015Q1$3.20$3.02$25.13 billion$25.20 billionViewN/AView Earnings Details
1/30/2015Q4$2.48$0.38$24.67 billion$24.59 billionViewN/AView Earnings Details
10/30/2014Q3$2.45$2.47$22.25 billion$22.25 billionViewN/AView Earnings Details
8/7/2014Q2$2.60$0.48$21.86 billion$21.63 billionViewN/AView Earnings Details
5/1/2014Q1$2.37$2.43$20.83 billion$20.30 billionViewN/AView Earnings Details
1/28/2014Q413$0.42ViewN/AView Earnings Details
10/31/2013Q1$12.11$2.20$21.04 billion$20.51 billionViewN/AView Earnings Details
8/8/2013Q1$11.97$12.45$21.09 billion$21.38 billionViewN/AView Earnings Details
5/1/2013$10.67$10.98$19.73 billion$19.98 billionViewN/AView Earnings Details
1/31/2013$9.77$10.53$20.83 billion$20.96 billionViewN/AView Earnings Details
10/31/2012Q312$9.43$10.33$57.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Novo Nordisk A/S (NYSE:NVO)
Current Year EPS Consensus Estimate: $2.26 EPS
Next Year EPS Consensus Estimate: $2.5 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.39$0.53$0.48
Q2 20162$0.57$0.58$0.58
Q3 20161$0.54$0.54$0.54
Q4 20161$0.52$0.52$0.52
(Data provided by Zacks Investment Research)


Current Dividend Information for Novo Nordisk A/S (NYSE:NVO)
Annual Dividend:$1.03
Dividend Yield:2.20%
Payout Ratio:48.82% (Based on Trailing 12 Months of Earnings)
45.58% (Based on Current Year Consensus EPS Estimate)
41.20% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:13.30% (3 Year Average)

Dividend History for Novo Nordisk A/S (NYSE:NVO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Novo Nordisk A/S (NYSE:NVO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/18/2015Richmond Partners Master LimitInsiderSell24,900$1.28$31,876.98
(Data available from 1/1/2013 forward)


Latest Headlines for Novo Nordisk A/S (NYSE:NVO)
News IconNovo Nordisk A/S (NYSE:NVO) from Drug Manufacturers – Other – Todays Top Gains (NYSE:NVO) - August 24 at 6:16 PM logoWhy Did Novo Lower 2016 Sales Guidance? (NYSE:NVO) - August 24 at 9:39 AM
News IconA look at a High Market Cap Stock: Novo Nordisk A/S, NVO - The Daily Leicester (NYSE:NVO) - August 23 at 6:44 PM logoWhat’s Challenging Novo’s Leadership in the US Diabetes Space? (NYSE:NVO) - August 23 at 6:44 PM
News IconToday's Top Gainers in the Market Novo Nordisk A/S (NYSE:NVO ... - The Daily Leicester (NYSE:NVO) - August 23 at 10:58 AM logoWhat Are the Prospects for Novo’s Biopharmaceuticals Segment? (NYSE:NVO) - August 23 at 10:58 AM logoFDA’s Sanofi SA (ADR) (NYSE:SNY) Delay Highlights Some Red Flags With IGlarLixi (NYSE:NVO) - August 22 at 11:07 AM
News IconIs Novo Nordisk A/S(NYSE: NVO), a large market cap stock a smart ... - The Daily Leicester (NYSE:NVO) - August 21 at 10:38 AM
News IconLarge Cap Drug Manufacturers – Other: Novo Nordisk A/S (NYSE:NVO) (NYSE:NVO) - August 17 at 6:49 PM
News IconNotable Stocks Buzz: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), Novo Nordisk A/S (ADR)(NYSE:NVO) - NYSE Journal (press release) (NYSE:NVO) - August 17 at 9:37 AM logoNovo Nordisk A/S Focuses on New Drugs (NYSE:NVO) - August 16 at 3:19 PM logoEmisphere Reports Second Quarter 2016 Financial Results (NYSE:NVO) - August 15 at 8:46 AM
News IconUpdate on Novo Nordisk A/S (NYSE:NVO) for the day (NYSE:NVO) - August 13 at 9:28 AM logoNovo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for August 11, 2016 - Nasdaq (NYSE:NVO) - August 12 at 9:46 AM logoETF’s with exposure to Novo Nordisk A/S : August 11, 2016 (NYSE:NVO) - August 11 at 7:01 PM
News IconIs Novo Nordisk A/S (NYSE:NVO), a large market cap stock a smart buy? (NYSE:NVO) - August 11 at 9:46 AM logoNovo Nordisk A/S :NVO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NYSE:NVO) - August 10 at 7:00 PM logoPost Earnings Coverage as Novo Nordisk Tops Profit Expectations with 23 Percent Growth (NYSE:NVO) - August 10 at 9:40 AM logoA Look at Novo’s 2Q16 Revenue and Earnings (NYSE:NVO) - August 9 at 6:49 PM logoHow Did Novo Nordisk Perform across Geographies in 1H16? (NYSE:NVO) - August 9 at 6:49 PM
News IconThe Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP) (NYSE:NVO) - August 9 at 1:02 PM logoNovo Nordisk A/S (NVO) Is Today's Pre-Market Mover With Heavy Volume Stock (NYSE:NVO) - August 9 at 9:46 AM logoNovo Nordisk A/S : increased adjusted operating profit by 8% in local currencies in the first six months of 2016 (NYSE:NVO) - August 8 at 11:15 AM logoAnalyst Downgrades: FireEye Inc, Novo Nordisk A/S, and Bristol-Myers Squibb Co (NYSE:NVO) - August 8 at 11:15 AM
News IconUpdate on Novo Nordisk A/S (NYSE:NVO) for the day - Twin County News (NYSE:NVO) - August 6 at 6:40 PM logoTrade-Ideas: Novo Nordisk A/S (NVO) Is Today's Weak On High Relative Volume Stock - (NYSE:NVO) - August 6 at 6:40 PM
News IconNovo Nordisk H1 Profit Rises, To Pay Dividend; Cuts FY16 Growth View (NYSE:NVO) - August 5 at 6:45 PM logoNotable Two Hundred Day Moving Average Cross - NVO (NYSE:NVO) - August 5 at 6:45 PM logoNovo Nordisk beats 2Q profit forecasts (NYSE:NVO) - August 5 at 6:45 PM logoNovo-Nordisk is Oversold (NYSE:NVO) - August 5 at 6:45 PM
News IconLeading stocks in today’s market: Novo Nordisk A/S (NYSE:NVO) (NYSE:NVO) - August 5 at 6:45 PM logoWhy Novo Nordisk A/S Tumbled Today (NYSE:NVO) - August 5 at 1:54 PM logoAnalysts Actions to Track: Gilead Sciences, Inc. (NASDAQ:GILD) , Novo Nordisk A/S (NYSE:NVO) - Street Updates (NYSE:NVO) - August 5 at 9:38 AM logoNovo Nordisk Stock Slips on Lowered Guidance, US Market Competitiveness - Bidness ETC (NYSE:NVO) - August 5 at 9:38 AM logoEuropean shares lifted by solid earnings but RBS slumps (NYSE:NVO) - August 5 at 9:38 AM logoSam Isaly Adds to Stake in Novo Nordisk (NYSE:NVO) - August 4 at 6:57 PM
News IconNovo Nordisk A/S (NYSE:NVO) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NYSE:NVO) - August 3 at 6:56 PM logoNovo Nordisk A/S (NVO): Heavy Pre-Market Activity - TheStreet - (NYSE:NVO) - August 3 at 6:56 PM logoHow Much Growth Will Novo See in 2Q16? (NYSE:NVO) - August 1 at 6:19 PM
News IconNovo Nordisk A/S (NYSE:NVO) – Top Stock from Healthcare Sector ... - The Daily Leicester (NYSE:NVO) - July 29 at 6:42 PM
News IconA look at a High Market Cap Stock: Novo Nordisk A/S, NVO – The ... - The Daily Leicester (NYSE:NVO) - July 27 at 9:36 AM logoNovo Nordisk A/S (NYSE:NVO) Updated Price Targets - FTSE News ... - FTSE News (NYSE:NVO) - July 26 at 9:49 AM logoNovo Nordisk A/S (NVO) Shares are Up 0.91% – Trade Calls - Trade Calls (NYSE:NVO) - July 26 at 9:49 AM
News IconNovo Nordisk A/S (NYSE:NVO): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NYSE:NVO) - July 22 at 9:30 AM
News IconToday's Top Gainers in the Market Novo Nordisk A/S (NYSE:NVO) from Healthcare - The Daily Leicester (NYSE:NVO) - July 22 at 9:30 AM logoShares of Novo Nordisk A/S (NVO) Rally 1.04% - Trade Calls (NYSE:NVO) - July 20 at 7:18 PM
News IconStock Focus: Following Analyst Expectations on Shares of Novo Nordisk A/S (NYSE:NVO) - TGP (NYSE:NVO) - July 19 at 6:41 PM
News IconEquity Roundup: Stock Performance Focus on Novo Nordisk A/S (NYSE:NVO) - Press Telegraph (NYSE:NVO) - July 19 at 6:41 PM
News IconLong Term Value Play: Novo Nordisk A/S (NYSE:NVO) - TGP (NYSE:NVO) - July 19 at 6:41 PM
News IconAnalyst Target and Average Rating Watch: Novo Nordisk A/S (NYSE:NVO) - Press Telegraph (NYSE:NVO) - July 18 at 6:40 PM


Novo Nordisk A/S (NYSE:NVO) Chart for Friday, August, 26, 2016

Last Updated on 8/26/2016 by Staff